Financhill
Back

Rocket Pharmaceuticals Quote, Financials, Valuation and Earnings

Rocket Pharmaceuticals Price Quote

$16.66
-0.01 (-2%)
(Updated: March 25, 2023 at 5:24 AM ET)

Rocket Pharmaceuticals Key Stats

Sell
48
Rocket Pharmaceuticals (RCKT) is a Sell

Day range:
$16.23 - $17.19
52-week range:
$7.57 - $23.48
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.7%

Volume:
934.2K
Avg. volume:
945.4K
1-year change:
4.06%
Market cap:
$1.3B
Revenue:
$0
EPS:
$-3.26

How Much Does Rocket Pharmaceuticals Make?

Data Unavailable

Is Rocket Pharmaceuticals Growing As A Company?

Data Unavailable

Rocket Pharmaceuticals Stock Price Performance

What Is Rocket Pharmaceuticals 52-Week High & Low?

Rocket Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rocket Pharmaceuticals?

Is Rocket Pharmaceuticals Cash Flow Positive?

  • What Is RCKT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$178.1M
  • What Is Rocket Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $155.3M
  • What Is Rocket Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$69.3M

Rocket Pharmaceuticals Return On Invested Capital

Data Unavailable

Rocket Pharmaceuticals Earnings Date & Stock Price

Rocket Pharmaceuticals Competitors

Rocket Pharmaceuticals Dividend Yield

Data Unavailable

Rocket Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -8.06%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 12
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 50.64
Upside from Last Price: 203.8%

Major Shareholders

  • How many RCKT shares are owned by institutional investors?
    116.2M RCKT shares are owned by institutional investors
  • How many RCKT shares are owned by insiders?
    924.6K RCKT shares are owned by insiders